AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
With a market cap of 252.28B, AstraZeneca(AZN) trades at $163.07. The stock has a price-to-earnings ratio of 24.15 and currently yields dividends of 1.68%.
On 2026-09-06, AstraZeneca(AZN) stock moved within a range of $161.13 to $164.57. With shares now at $163.07, the stock is trading +1.2% above its intraday low and -0.9% below the session's peak.
Trading activity shows a volume of 3.07M, compared to an average daily volume of 2.88M.
Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $145.79.
Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $145.79.
AZN News
...
The U.S. Food and Drug Administration expanded treatment options for adult patients with advanced breast cancer, reflecting the FDA’s commitment to advancing me...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. AstraZeneca has launched a new Phase I study, formally titled “A Phase I, Single-...
Analyst ratings
100%
of 10 ratingsMore AZN News
AstraZeneca (AZN) Pharmaceuticals was granted FDA orphan designation for a treatment of hepatocellular carcinoma, according to a post to the agency’s website....
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. AstraZeneca’s new CHARM Hepatocellular Carcinoma MEA Study tracks how liver cance...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The CARDIO-TTRansform study is a Phase 3 trial that tests eplontersen in patients with...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The study A Non-interventional Study Evaluating Samples From Patients With Suspected N...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The Phase I study “A Phase I, Open-label Study to Assess the Absolute Bioavailability...
Wednesday, September 2, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research rep...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. The AstraZeneca GRACE Study Tracks Real-World Care For Gastric Cancer In Greece....
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.